AV
Atlas Ventures
Venture CapitalActiveAtlas Ventures is an early stage VC fund
14
Investments
10
Exits
$3.5B
AUM
71.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Atlas Ventures.
Investment Thesis & Strategy
Atlas Ventures invests in early-stage companies across various industries, providing capital and guidance to help them grow and scale.
Notable Exits
CompanyTypeYearValue / Acquirer
StripeIPO2025$95B
Obsidian TherapeuticsIPO2024—
Adicet BioIPO2021—
VisterraAcquisition2021—
Kiadis PharmaAcquisition2020$87.5M
MomentaAcquisition2020$1.15B
AVROBIOIPO2018—
Surface OncologyIPO2018—
Selecta BiosciencesIPO2017—
Corvus PharmaceuticalsIPO2017—
Frequently Asked Questions
Atlas Ventures focuses on Series A, Series B, Series C+ stage investments.